Tammenoms Bakker Juliet's Form 4 filing
RxSight, Inc. (RXST) · filed Feb 15, 2024
- Accession no.
- 0000950170-24-015900
- Filed
- Feb 15, 2024
- Trade date
- Feb 12-14, 2024
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $406.7K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tammenoms Bakker JulietCIK 0001431159 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Common Stock | PPurchaseAcquired | +4,000 | $50.38 | +$201,520 | 25,840 | Direct | |
| Feb 14, 2024 | Common Stock | PPurchaseAcquired | +4,000 | $51.29 | +$205,160 | 29,840 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.